Technical Analysis for MYOV - Myovant Sciences Ltd.

Grade Last Price % Change Price Change
grade A 23.2 -2.27% -0.54
MYOV closed down 2.27 percent on Friday, March 22, 2019, on 54 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MYOV trend table...

Date Alert Name Type % Chg
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 Spinning Top Other -2.27%
Mar 21 Volume Surge Other -2.27%
Mar 21 Upper Bollinger Band Walk Strength -2.27%
Mar 21 Upper Bollinger Band Touch Strength -2.27%
Mar 20 MACD Bullish Signal Line Cross Bullish -4.49%
Mar 20 Pocket Pivot Bullish Swing Setup -4.49%
Mar 20 Volume Surge Other -4.49%
Mar 20 BB Squeeze Ended Range Expansion -4.49%

Older signals for MYOV ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company also intends to develop RVT-602, an oligopeptide kisspeptin analog, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. was founded in 2016 and is based in Hamilton, Bermuda. Myovant Sciences Ltd. operates as a subsidiary of Roivant Sciences Ltd.
Chemistry Biopharmaceutical Pain Prostate Cancer Endocrine System Hormones Amines Pyrimidines Gnrh Antagonists Gonadotropin Releasing Hormone Antagonist Roivant Sciences Uterine Fibroids
Is MYOV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 27.45
52 Week Low 14.32
Average Volume 79,764
200-Day Moving Average 21.0575
50-Day Moving Average 20.4778
20-Day Moving Average 22.533
10-Day Moving Average 22.778
Average True Range 1.0733
ADX 47.16
+DI 28.9633
-DI 8.3725
Chandelier Exit (Long, 3 ATRs ) 21.7301
Chandelier Exit (Short, 3 ATRs ) 23.8899
Upper Bollinger Band 23.9007
Lower Bollinger Band 21.1653
Percent B (%b) 0.74
BandWidth 12.139529
MACD Line 0.7837
MACD Signal Line 0.7743
MACD Histogram 0.0094
Fundamentals Value
Market Cap 1.41 Billion
Num Shares 60.8 Million
EPS -1.63
Price-to-Earnings (P/E) Ratio -14.23
Price-to-Sales 0.00
Price-to-Book 5.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.90
Resistance 3 (R3) 25.03 24.59 24.61
Resistance 2 (R2) 24.59 24.16 24.53 24.52
Resistance 1 (R1) 23.90 23.89 23.68 23.77 24.42
Pivot Point 23.46 23.46 23.36 23.40 23.46
Support 1 (S1) 22.77 23.03 22.55 22.64 21.98
Support 2 (S2) 22.33 22.76 22.27 21.88
Support 3 (S3) 21.64 22.33 21.79
Support 4 (S4) 21.51